Kanaiyalal R Patel

Title: Kanaiyalal R Patel: Innovator in Biopharmaceutical Formulations

Introduction

Kanaiyalal R Patel is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of formulations for the extended release of biologically-active polypeptides. With a total of 6 patents to his name, Patel's work has the potential to enhance the efficacy of therapeutic agents.

Latest Patents

Patel's latest patents include innovative formulations aimed at improving the delivery of somatotropin. One of his key inventions is a non-aqueous injectable formulation that allows for the extended release and enhanced bioavailability of somatotropin. This composition comprises somatotropin, a bioavailability-enhancing constituent (BEC), and a substantially non-aqueous, hydrophobic excipient. The BEC may include various compounds such as amino acids, hydroxamate derivatives, non-reducing carbohydrates, and oxo-acid salts. Another significant patent focuses on non-aqueous surfactant-containing formulations for the same purpose, utilizing a first BEC that is typically a surfactant or a cyclodextrin compound.

Career Highlights

Throughout his career, Patel has worked with prominent companies in the biopharmaceutical sector, including Monsanto Technology LLC and G.D. Searle & Company. His experience in these organizations has contributed to his expertise in developing innovative drug delivery systems.

Collaborations

Patel has collaborated with notable colleagues such as Yunhua N Jeng and Lucia G Marshall. These partnerships have likely facilitated the advancement of his research and the successful development of his patented formulations.

Conclusion

Kanaiyalal R Patel's contributions to the field of biopharmaceuticals through his innovative patents demonstrate his commitment to improving therapeutic delivery systems. His work continues to influence the development of effective treatments in the medical field.